Jane Street’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-55,700
Closed -$123K 12395
2025
Q4
$123K Buy
+55,700
New +$105K ﹤0.01% 10065
2024
Q1
Sell
-45,300
Closed -$578K 9716
2023
Q4
$578K Hold
45,300
﹤0.01% 6518
2023
Q3
$468K Sell
45,300
-54,000
-54% -$625K ﹤0.01% 6393
2023
Q2
$1.3M Sell
99,300
-328,900
-77% -$4.02M ﹤0.01% 4806
2023
Q1
$4.79M Buy
+428,200
New +$4.23M ﹤0.01% 2528
2022
Q3
Sell
-105,400
Closed -$1.55M 10126
2022
Q2
$1.55M Sell
105,400
-2,500
-2% -$51.5K ﹤0.01% 4645
2022
Q1
$2.68M Buy
107,900
+55,800
+107% +$1.44M ﹤0.01% 4194
2021
Q4
$1.67M Buy
+52,100
New +$1.9M ﹤0.01% 4839
2021
Q3
Sell
-64,000
Closed -$2.82M 10388
2021
Q2
$2.82M Buy
+64,000
New +$2.79M ﹤0.01% 3674

Other funds holding LUNG

Jane Street's LUNG Position: Q2 2026 in Review

Jane Street increased its Pulmonx (LUNG) stake by 469% in Q2 2026, buying an estimated $861K and bringing the position to 758,231 shares worth $986K. The position accounts for ﹤0.01% of the portfolio, ranked #6584.

Jane Street first reported a position in LUNG in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.55M in Q1 2022. 107 funds tracked by Wall St. Rank hold LUNG as of Q2 2026.

  • Jane Street held 758,231 shares of Pulmonx worth $986K as of Q2 2026.
  • Jane Street bought 624,961 Pulmonx shares in Q2 2026, an estimated $861K.
  • Pulmonx made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #6584 holding.
  • Jane Street first reported a position in Pulmonx in Q1 2021 and has held it in 18 quarters since.
  • Jane Street's Pulmonx position peaked at $1.55M in Q1 2022.
  • 107 funds tracked by Wall St. Rank held Pulmonx as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.